Skip to the main content.

Cell and Gene Therapy Series. Part 2

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 2

PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?

Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.

This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French: 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future This article traces the evolution of API-in-capsule (AIC)...

Read More
What does Annex 1 mean for the cell & gene industry? Insights from 3P innovation.

What does Annex 1 mean for the cell & gene industry? Insights from 3P innovation.

Charles Pilato: 17 July 2025

The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...

Read More
How do we reduce your Environmental Cost of Ownership (ECO)?

How do we reduce your Environmental Cost of Ownership (ECO)?

David Johnson: 16 July 2025

Today’s pharmaceutical landscape positions 'sustainability' as an operational imperative. Manufacturers face increasing regulatory, societal, and...

Read More